A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view
- PMID: 16897593
- DOI: 10.1007/s00702-006-0560-0
A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view
Similar articles
-
[Drug therapy in Parkinson's disease].Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):234-40. Ned Tijdschr Geneeskd. 1999. PMID: 10086151 Review. Dutch.
-
Dopaminergic drugs in development for Parkinson's disease.Adv Neurol. 2003;91:267-71. Adv Neurol. 2003. PMID: 12442685 Review. No abstract available.
-
Dopamine and eating behavior disorders in Parkinson's disease: A complex recipe.Mov Disord. 2019 Jun;34(6):767-768. doi: 10.1002/mds.27703. Mov Disord. 2019. PMID: 31206832 No abstract available.
-
Dopamine agonists in the treatment of prolactinoma: are they still first choice?Intern Med J. 2011 Feb;41(2):156-61. doi: 10.1111/j.1445-5994.2010.02410.x. Intern Med J. 2011. PMID: 21138511 Review.
-
Should levodopa be used anymore?Acta Neurol Belg. 2002 Dec;102(4):163-6. Acta Neurol Belg. 2002. PMID: 12534242 Review.
Cited by
-
Cabergoline associated with first episode mania.Psychosomatics. 2012 Nov-Dec;53(6):595-600. doi: 10.1016/j.psym.2012.01.005. Epub 2012 May 31. Psychosomatics. 2012. PMID: 22658326 Free PMC article. No abstract available.
-
Integrating Neurology and Psychiatry throughout Educational Curricula for Healthcare Professionals.J Exp Neurol. 2020;1(4):168-172. doi: 10.33696/neurol.1.026. J Exp Neurol. 2020. PMID: 33860284 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases